News items related to: News
-
Civil society files lawsuit against Thai Department of Intellectual Property as “failure to reject TB patent is unlawful”
Translated from the original press release published in Thai, by The Standard and Prachathai. On 2 February 2021, a civil...
-
“No more delay – reject patent request for potential COVID-19 drug” urges Thai civil society
Japanese company Fujifilm-Toyama has filed for patents on favipiravir in Thailand. Favipiravir is an antiviral drug which has been used...
-
Pan-genotypic Hep-C drug added to Thai health system
The first pan-genotypic Hepatitis C drug, which can be prescribed without the requirement for expensive and limited testing to determine...
-
Getting India’s struggling Hep-C services re-open during COVID-19
For the estimated 6-12 million people living with Hepatitis C in India, access to treatment was already way below the...
-
Russian government issues its first health-related compulsory license
A new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
-
New data demonstrates the impact of patents in Ukraine
2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
-
A Tribute: Dr. Mongkol Na Songkhla – Putting Health Before Trade
We join our partner in Thailand, and activists around the world, to pay tribute to Dr. Mongkol Na Songkhla, a...
-
Thailand submits patent opposition on TB drug for children
Johnson & Johnson’s TB drug, bedaquiline (BDQ) can improve lives. The pediatric version is not substantially different to the adult...
-
Vietnam’s route to optimal, affordable HIV treatment
Following civil society advice, Vietnam’s Ministry of Health recommended TLD for HIV treatment. This was back in November 2019. Vietnam...
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
-
HIV activists are essential to the COVID-19 response
The legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...
-
COVID-19 vaccine announcements: Our view
Following on from the BioNTech and Pfizer vaccine announcement earlier this month, where we expressed cautious optimism, but also the...